I write this blog post just after returning from the 2023 MHRA GMP Symposium in London. It has been more than two years since we held our...

I write this blog post just after returning from the 2023 MHRA GMP Symposium in London. It has been more than two years since we held our...

The first hybrid GMDP Symposium was held on 21-22 February 2023. For the first time, we offered delegates the opportunity to either watch...

The first hybrid GMDP Symposium was held on 21-22 February 2023. For the first time, we offered delegates the opportunity to either watch...

From Monday 7 to Friday 11 March 2022, the MHRA will be hosting a week-long series of events as part of the Good Practice Symposia Week. ...

From Monday 7 to Friday 11 March 2022, the MHRA will be hosting a week-long series of events as part of the Good Practice Symposia Week. ...

The MHRA has launched an  8-week public consultation on proposals for legislative changes for clinical trials. Following the UK’s exit...

The MHRA has launched an  8-week public consultation on proposals for legislative changes for clinical trials. Following the UK’s exit...

On 13 August 2021, the Medicines & Healthcare products Regulatory Agency (MHRA) held a webinar to provide information and guidance around...

On 13 August 2021, the Medicines & Healthcare products Regulatory Agency (MHRA) held a webinar to provide information and guidance around...

MHRA, US-FDA and Health Canada colleagues at the London 2020 GCP symposium The second Medicines and Healthcare products Regulatory Agency...

MHRA, US-FDA and Health Canada colleagues at the London 2020 GCP symposium The second Medicines and Healthcare products Regulatory Agency...

The GPvP Inspectorate is planning the Good Pharmacovigilance Practice (GPvP) Symposium 2022 and we are very keen for you to engage and...

The GPvP Inspectorate is planning the Good Pharmacovigilance Practice (GPvP) Symposium 2022 and we are very keen for you to engage and...

Preventing falsified medicines entering the legal supply chain is a fundamental objective of good distribution practice (GDP) for...

Preventing falsified medicines entering the legal supply chain is a fundamental objective of good distribution practice (GDP) for...

The International Council for Harmonisation (ICH) E6 on Good Clinical Practice (GCP) is currently undergoing a major revision. ICH E6...

The International Council for Harmonisation (ICH) E6 on Good Clinical Practice (GCP) is currently undergoing a major revision. ICH E6...

Pharmacovigilance requirements for UK authorised products webinar recording, which took place on 13 January 2020. This webinar was part...

Pharmacovigilance requirements for UK authorised products webinar recording, which took place on 13 January 2020. This webinar was part...